RXO insider updates Form 4/A to add RSU holdings and share buy
Rhea-AI Filing Summary
RXO, Inc. director reported an open-market purchase of 9,350 shares of common stock on 11/17/2025 at a weighted average price of $10.75, bringing direct ownership to 91,137 shares.
The filing also shows beneficial ownership of restricted stock units (RSUs), including 7,745 RSUs that vest in full on January 2, 2026, and 126,260 RSUs that have vested and are subject to a deferral election. Each RSU represents the right to receive either one share of RXO common stock or a cash amount equal to its fair market value upon settlement.
The amendment was made solely to voluntarily include the director’s beneficial ownership of RSUs reported in Table II.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 9,350 | $10.75 | $101K |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Footnotes (1)
- The purchase price ranged from $10.74 to $10.76, with a weighted average purchase price of $10.75. Upon request, the Reporting Person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Each RSU represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. The RSUs shall vest in full on January 2, 2026, subject to the Reporting Person's continued service as a director of the Issuer. The RSUs vested in full and are subject to a deferral election. Shares of Common Stock will be delivered to the Reporting Person as per the terms of the deferral election.
FAQ
What insider transaction did RXO (RXO) report in this Form 4/A?
The director reported buying 9,350 shares of RXO common stock on 11/17/2025 in an open-market transaction at a weighted average price of $10.75 per share.
What RSU awards are disclosed for the RXO director in this filing?
The filing shows 7,745 restricted stock units (RSUs) and an additional 126,260 RSUs, each representing a right to receive either one RXO share or cash equal to its fair market value upon settlement.
When do the RXO restricted stock units reported here vest?
The 7,745 RSUs are scheduled to vest in full on January 2, 2026, subject to the director’s continued service. The 126,260 RSUs have already vested and are subject to a deferral election.
What does it mean that some RXO RSUs are subject to a deferral election?
For the 126,260 vested RSUs, delivery of RXO common stock is deferred. The shares will be delivered to the director according to the terms of the deferral election described in the award documents.
Why was this RXO Form 4/A amended?
The amendment was made solely to voluntarily include the director’s beneficial ownership of the derivative securities (RSUs) reported in Table II.